# P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

> **NCT01854567** · PHASE3 · COMPLETED · sponsor: **Mesoblast, Ltd.** · enrollment: 49 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Acute Lymphoblastic Leukemia
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease

## Interventions

- **BIOLOGICAL:** Infusion of one MPC expanded cord unit and one unexpanded cord unit
- **BIOLOGICAL:** Infusion of two unexpanded cord blood units.

## Key facts

- **NCT ID:** NCT01854567
- **Lead sponsor:** Mesoblast, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-09-23
- **Final completion:** 2017-05-05
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854567, "P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01854567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*